Actos (pioglitazone): Ongoing Safety Review – Potential Increased Risk of Bladder Cancer
Audience: Endocrinology, Family Practice, Urology [UPDATED 06/15/2011]Â Use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added…
Related posts:
- Diabetes Drug Actos Linked to Bladder Cancer After reviewing official reports of bad drug reactions, health officials...
- Abacavir – Ongoing Safety Review: Possible Increased Risk of Heart Attack Audience: Infectious Disease including Ziagen, Trizivir, and Epzicom ISSUE: FDA...




facebook
rss
twitter